Skip to Main Content

Paper Details

When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?
Clin Pharmacol Ther
14
2022
Author NameAffiliation
Richard PlattHarvard Pilgrim Health Care Institute, Harvard Medical School
Alex John LondonPhilosophy Department & Center for Ethics and Policy, Carnegie Mellon University
Gregory E SimonKaiser Permanente Washington Health Research Institute
Michael A HorbergKaiser Permanente Mid-Atlantic Permanente Research Institute and Mid-Atlantic Permanente Medical Group
Adrian F HernandezDuke Clinical Research Institute
Robert M CaliffVerily Life Sciences and Google Health
Robert M CaliffVerily Life Sciences and Google Health
  • 1 - 7

Datasets

Release 1.2